Background: A new prediction score for DCD liver transplants (UK-DCD-Risk-Score) has been recently reported using the largest available Maastricht Type-III DCD cohort from UK (n = 1153). Donor and recipient factors, which accumulate to more than 10 score points, reliably predicted futile outcomes of <40% 1 y graft survival due to primarynon-function (PNF) or ischemic cholangiopathy. The aim of this study was to show, whether outcome in such high-risk DCD liver transplants is more favorable when applying an endischemic machine perfusion technique, developed in our center, hypothermic oxygenated perfusion (HOPE). Methods: High-risk DCD combinations were selected from our entire cohort of HOPE-treated human DCD liver grafts, with a minimum follow-up period of 1 y (n = 50). Risk combinations include DCD grafts from elderly donors (>60 years) with prolonged functional donor warm ischemia time (fDWIT, >30 min), cold ischemia time > 6 hrs, and elevated donor BMI (>25 kg/m 2 ). Recipient risk factors involved retransplantation, advanced recipient age (>60 years) and labMELD > 25.
Results: Twenty-one high risk DCD LT (21/50, 42%) deemed futile (median UK-DCD-Risk-Score: 11, IQR: 11e12) were identified. None of the recipients developed PNF. Three grafts were lost due to hepatic artery thrombosis, chronic rejection and non-anastomotic stricture, respectively. One-year overall graft survival was 86%, and 5-year non-tumor related graft survival was also 86%. Importantly, HOPE-treatment allowed an 88 % graft utilization rate (50 livers implanted/57 livers procured) during a 5-year study period. Conclusion: HOPE-treatment achieved excellent outcomes, despite high-risk donor and recipient combinations. Such easy endischemic perfusion approach may therefore open the door for an increased utilization of futile DCD livers in other countries.
PL03-03 A RANDOMIZED CONTROLLED TRIAL FOR EVALUATION OF ROUTINE USE OF POSTOPERATIVE NASOGASTRIC TUBE DECOMPRESSION AFTER PANCREATICODUODENECTOMY
O. Barakat, M. Cagigas and C. Ozaki Surgery, Baylor College of Medicine, United States Introduction: Nasogastric decompression (NGD) has been routinely used after major gastrointestinal surgery. The purpose of this randomized controlled trial (RCT) is to evaluate the benefit of NGD in the early postoperative period as compared to routine intra-operative oro-gastric tube (OGT) decompression, in patient undergoing pancreaticoduodenectomy (PD). Methods: Over 4-year period, a total of 120 patients undergoing PD were enrolled in this prospective RCT. There were 57 patients in group 1 (OGT) and 63 patient in group II (NGT). Postoperative variables evaluated, were time to starting oral diet, Incidence of postoperative nausea and vomiting, Postoperative ileus, delayed gastric emptying (DGE), NGT re-insertion rate, anastomotic leak, pulmonary complication, length of hospital stay (LOS), and mortality. Results: There were no significant difference between both groups in regard to the preoperative and intra-operative variables. However, time to oral diet was significantly HPB 2018, 20 (S2), S173eS178
Plenaries S177
